Trak

About:

Sandstone Diagnostics provides an integrated wellness technology that empowers consumers to measure, monitor, and improve their health.

Website: https://trakfertility.com/

Twitter/X: trakfertility

Top Investors: LabCorp, StartUp Health, Sand Hill Angels, 37 Angels, Portfolia

Description:

Sandstone Diagnostics is a Bay Area biotech company developing instruments and consumables for point-of-care medical testing. Sandstone’s lead product, Trak, is a consumer semen analysis platform that provides a simple and accurate way to monitor sperm quality from the comfort of home. Trak is a tool for men to take charge of their fertility, boost their sperm quality, and improve their chances of conception. Sandstone was co-founded in 2012 by Ph.D. scientists developing medical technologies for national defense applications at Sandia National Laboratories.

Total Funding Amount:

$11M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Livermore, California, United States

Founded Date:

2012-04-01

Contact Email:

info(AT)sandstonedx.com

Founders:

Greg Sommer, Sara Naab, Ulrich Schaff

Number of Employees:

1-10

Last Funding Date:

2019-05-06

IPO Status:

Private

Industries:

© 2025 bioDAO.ai